ReviewPharmaceuticals (Basel, Switzerland)2022

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib.

Annalisa Marcuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.